Journal article

The ART of loss: A beta imaging in the evaluation of Alzheimer's disease and other dementias

Victor L Villemagne, Michelle T Fodero-Tavoletti, Kerryn E Pike, Roberto Cappai, Colin L Masters, Christopher C Rowe



Molecular neuroimaging based on annihilation radiation tomographic (ART) techniques such as positron emission tomography (PET), in conjunction with related biomarkers in plasma and cerebrospinal fluid (CSF), are proving valuable in the early and differential diagnosis of Alzheimer's disease (AD). With the advent of new therapeutic strategies aimed at reducing beta-amyloid (Abeta) burden in the brain to potentially prevent or delay functional and irreversible cognitive loss, there is increased interest in developing agents that allow assessment of Abeta burden in vivo. Abeta burden as assessed by molecular imaging matches histopathological reports of Abeta plaque distribution in aging and dem..

View full abstract